Cardiac Science (Weighted Average Cost of Capital (WACC) Analysis)
 Improve your investment analysis with by seeing the Cardiac Science's Discounted Cash Flow analysis, Cardiac Science's Warren Buffet analysis, and Cardiac Science's Comparable Multiple analysis.  Helpful Information for Cardiac Science's AnalysisWhat is the WACC Formula? Analyst use the WACC Discount Rate (weighted average cost of capital) to determine Cardiac Science's investment risk. WACC Formula = Cost of Equity (CAPM) * Common Equity + (Cost of Debt) * Total Debt. The result of this calculation is an essential input for the discounted cash flow (DCF) analysis for Cardiac Science. Value Investing Importance? This method is widely used by investment professionals to determine the correct price for investments in Cardiac Science before they make value investing decisions. This WACC analysis is used in Cardiac Science's discounted cash flow (DCF) valuation and see how the WACC calculation affect's Cardiac Science's company valuation. |
WACC Analysis Information1. The WACC (discount rate) calculation for Cardiac Science uses comparable companies to produce a single WACC (discount rate). An industry average WACC (discount rate) is the most accurate for Cardiac Science over the long term. If there are any short-term differences between the industry WACC and Cardiac Science's WACC (discount rate), then Cardiac Science is more likely to revert to the industry WACC (discount rate) over the long term. 2. The WACC calculation uses the higher of Cardiac Science's WACC or the risk free rate, because no investment can have a cost of capital that is better than risk free. This situation may occur if the beta is negative and Cardiac Science uses a significant proportion of equity capital. |
